Wednesday, August 31, 2016 5:20:39 PM
For me the website stuff is a bit more interesting, especially when you consider Cohen's remarks when they announced the original LOI had expired, basically left the door open for NovaRx should they reconsider.
Perhaps they did... and perhaps management has learned their lesson from before and has now reserved their public announcements for when things are signed, sealed, and delivered.
Wishful thinking until proven otherwise.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM